Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $543,840 - $619,680
-9,600 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$62.1 - $78.08 $596,160 - $749,568
9,600 New
9,600 $607,000
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $264,966 - $291,454
-4,300 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $268,793 - $296,700
4,300 New
4,300 $273,000
Q2 2018

Aug 14, 2018

SELL
$64.88 - $75.68 $181,664 - $211,904
-2,800 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$72.84 - $88.8 $203,952 - $248,640
2,800 New
2,800 $211,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.